Digestive Health Clinical Trials
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass (REIGNITE)
Learn MoreWhat is the purpose of this study?
The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a Roux-en-Y gastric bypass. Participants will randomized 2:1. Those randomized to the TORe arm will receive a TORe procedure and intensive lifestyle modification which consists of a well-balanced calorie restrictive diet, incorporation of exercise and coaching on lifestyle discussion. Participants randomized the lifestyle modification alone arm will be eligible to receive a TORe procedure at 6 months post enrollment. Total follow up will be 24 months.
Eligibility
- 18 years or older.
- Experiencing weight regain (≥ 20% weight from nadir) after achieving clinically successful weight loss.
- Willing to have a TORe procedure for the treatment of weight regain.
- BMI between 30 and 50 kg/m2, inclusive.
- GJA diameter ≥ 20 mm, confirmed either during a
- Screening EGD completed ≤ 60 days from study procedure or
- EGD performed immediately prior to the TORe procedure.
- Anatomically accepting of the procedure, including a pouch size that will not require reduction at the time of treatment (pouch that is shorter than 6 cm in length).
- Agrees not to take additional over the counter or prescribed weight loss supplements / medications (including incretins) during the first 6 months of the study.
- Is on a stable dose of anti-diabetic medication for three months with no anticipated changes during the first 6 months of the study.
- Agrees to the follow-up requirements of the study and is able to read, understand, and sign a written Informed Consent Form to participate in the study.
- Meets the indications for TORe procedure with OverStitch™ Endoscopic Suturing System.
- Current use or use within the three months prior to the baseline visit of over the counter or prescribed weight loss supplements / medications (including incretins).
- Current or planned management of Type 2 Diabetes with incretin medications.
- Inability or unwillingness to comply with assigned treatment or protocol requirements related to visits.
- Investigator's medical judgement that the subject is not a candidate for the TORe procedure.
- Current pregnancy confirmed by site standard of care or planned pregnancy or breastfeeding in the next two years.
- Vulnerable subject.
Where can I participate?
More about this Clinical TrialWhat is the full name of this Clinical Trial?
Prospective, Randomized Clinical Study Evaluating Transoral Outlet Reduction (TORe) and Lifestyle Modification for Patients With Weight Regain Following Roux-en-Y Gastric Bypass
- Disease Type/ConditionWeight Regain, Weight Loss
- Principal InvestigatorJennifer Phan, MD
- Age GroupAdult, Older Adult
- PhaseN/A
- ClinicalTrials.gov IDNCT07015424
- Key Eligibilityclinicaltrials.gov
- How do I learn more about this study?Laurie Hendricks
laurie.hendricks@hoag.org
Hoag Digestive Health Institute
Hoag Digestive Health Institute provides advanced, comprehensive care for the full spectrum of digestive conditions, with access to world-class specialists, diagnostics and imaging, advanced interventional therapeutics, and clinical trials. Patients benefit from a research-driven approach that connects leading-edge treatment options with personalized care across gastroenterology and GI surgery.
Stay up-to-date on the latest news from Hoag
By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.